Walleye Capital’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.32M | Buy |
119,885
+33,682
| +39% | +$932K | 0.01% | 487 |
|
|
2025
Q1 | $1.91M | Buy |
+86,203
| New | +$1.91M | 0.01% | 610 |
|
|
2024
Q1 | – | Sell |
-327,332
| Closed | -$5.74M | – | 2818 |
|
|
2023
Q4 | $5.74M | Buy |
+327,332
| New | +$5.74M | 0.01% | 318 |
|
|
2023
Q1 | – | Sell |
-48,217
| Closed | -$722K | – | 2453 |
|
|
2022
Q4 | $722K | Sell |
48,217
-175,018
| -78% | -$2.62M | 0.01% | 840 |
|
|
2022
Q3 | $2.87M | Sell |
223,235
-72,688
| -25% | -$933K | 0.05% | 335 |
|
|
2022
Q2 | $2.87M | Buy |
295,923
+194,313
| +191% | +$1.88M | 0.08% | 268 |
|
|
2022
Q1 | $1.01M | Buy |
101,610
+18,246
| +22% | +$181K | 0.03% | 609 |
|
|
2021
Q4 | $981K | Buy |
+83,364
| New | +$981K | 0.03% | 590 |
|